Einstein Experts for Media

Search Results

You searched for "type 2 diabetes"

6 results found

Nir Barzilai, M.D.

Nir Barzilai, M.D.

Professor, Medicine (Endocrinology)

Director, Institute for Aging Research

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

AgingBiology of agingLongevity genes

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times, PBS’ “NOVA scienceNow” and National Geographic. read more...

 

Jill P. Crandall, M.D.

Jill P. Crandall, M.D.

Professor, Department of Medicine (Endocrinology)

Jacob A. and Jeanne E. Barkey Chair in Medicine

Chief, Division of Endocrinology

Director, Fleischer Institute for Diabetes and Metabolism

DiabetesType 2 diabetesDiabetes prevention

Clinical TrialsPrediabetesResveratrol

An expert in diabetes prevention, Dr. Crandall is director of the Diabetes Clinical Trials Unit at Einstein and Montefiore and a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE) and the PERL (Preventing Early Renal Loss) study.  read more...

 

John M. Greally, Ph.D., D.Med., M.B.,B.Ch.,B.A.O.

John M. Greally, Ph.D., D.Med., M.B.,B.Ch.,B.A.O.

Director, Center for Epigenomics, Einstein

Faculty Scholar for Epigenomics, Einstein

Attending Physician, Pediatrics, The Children's Hospital at Montefiore

GeneticsEpigenetics/epigenomics

Dr. Greally began his career as a pediatrician who subspecialized in clinical genetics, seeing patients with genetic syndromes, birth defects and developmental problems. Now, Dr. Greally seeks to understand how genetic disease is caused not by DNA mutations, but due to abnormalities in how genes are switched off and on – a field known as epigenomics.  read more...

 

Meredith A. Hawkins, M.D., M.S.

Meredith A. Hawkins, M.D., M.S.

Professor, Medicine (Endocrinology), Einstein

Director, Global Diabetes Institute, Einstein

Attending Physician, Medicine, Montefiore Health System

Harold and Muriel Block Chair in Medicine, Einstein

DiabetesGlobal diabetesType 2 diabetes

Malnutrition diabetesGlobal health

Dr. Hawkins specializes in diabetes, with a particular emphasis on the dramatic rise of the disease worldwide. She has traveled the globe investigating diabetes since 1996 and is the founding director of the Global Diabetes Institute (GDI) at Einstein, which conducts diabetes education and training for healthcare workers in South and Central America, Eastern Europe, Africa and Asia. read more...

 

Elizabeth A. Walker, Ph.D.

Elizabeth A. Walker, Ph.D.

Professor, Medicine (Endocrinology)

Professor, Epidemiology & Population Health

Associate Director, Einstein-Mount Sinai Diabetes Research Center

Director of the Einstein Diabetes Prevention & Control Core

Diabetes Self-Management (behavior change)Type 2 diabetesBehavioral interventionPublic health

Dr. Walker is a nurse scientist, diabetes nurse specialist and certified diabetes educator who specializes in studying how to help people with diabetes better manage their disease by adhering to their medication regimen, eating a healthy diet, exercising, and getting regular screening for complications. She is recognized for leading large NIH-funded behavioral intervention studies in minority diabetes populations—and has a program of research studies showing that regular phone calls to people with diabetes can be successful in helping them self-manage their disease and improve their diabetes control.  read more...

 

Judith Wylie-Rosett, Ed.D.

Judith Wylie-Rosett, Ed.D.

Professor, Epidemiology & Population Health (Health Promotion and Nutrition Research)

Professor, Medicine (Endocrinology)

Division Head, Health Promotion and Nutritional Research, Department of Epidemiology & Population Health

Atran Foundation Chair in Social Medicine

NutritionObesityWeight management

Behavior modificationType 2 diabetes

Dr. Wylie-Rosett’s research focuses on nutrition’s role in preventing and controlling chronic diseases—particularly diseases such as type 2 diabetes and heart disease in which obesity is an important risk factor.  She is associate editor of the journal Diabetes Care and author of The Complete Weight Loss Workbook. Dr. Wylie-Rosett has helped the American Diabetes Association and American Heart Association develop nutrition-related recommendations and position statements. read more...